Scale Biosciences Continues Commercial Expansion with Introduction of New and Differentiated Single Cell Methylation and Single Cell RNA Sequencing Solutions

Scale Biosciences, Inc. (ScaleBioTM), an innovator in single cell sequencing leveraging combinatorial indexing technologies, today announced an expansion of their product portfolio to enable a broader range of single cell omics experiments and unlock new translational research applications.

A rare disease program, portrayed as both lifeline and pharma handout, is set to expire

After his son Michael was diagnosed with a devastating, ultra-rare disease in 2019, Terry Pirovolakis dedicated himself to eradicating it. Pirovolakis, a Canadian IT director,

September 12, 2024

White House drug shortage task force held rare in-person meeting with industry

Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us

August 3, 2023

Evox Therapeutics teams with New York medical school to co-develop AAV vectors – Pharmaceutical Technology

Exosomes are quickly taken up by cells and have rapid clearance from circulation, leading to an efficient delivery of therapeutic payloads to organs of interest.

August 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.